KAM
TARO
Krensavage Asset Management’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-650,089
| Closed | -$28M | – | 14 |
|
|
2024
Q2 | $28M | Buy |
650,089
+2,221
| +0.3% | +$95.5K | 12.83% | 4 |
|
|
2024
Q1 | $27.4M | Buy |
647,868
+1,415
| +0.2% | +$59.9K | 12.16% | 4 |
|
|
2023
Q4 | $27M | Buy |
646,453
+5,718
| +0.9% | +$239K | 9.58% | 6 |
|
|
2023
Q3 | $24.2M | Sell |
640,735
-2,345
| -0.4% | -$88.4K | 8.9% | 7 |
|
|
2023
Q2 | $24.4M | Buy |
643,080
+1,170
| +0.2% | +$44.4K | 7.73% | 7 |
|
|
2023
Q1 | $15.6M | Sell |
641,910
-2,754
| -0.4% | -$67K | 4.74% | 9 |
|
|
2022
Q4 | $18.7M | Buy |
644,664
+63,871
| +11% | +$1.85M | 5.78% | 9 |
|
|
2022
Q3 | $17.4M | Buy |
580,793
+269
| +0% | +$8.07K | 5.54% | 9 |
|
|
2022
Q2 | $21M | Buy |
580,524
+14,573
| +3% | +$527K | 6.94% | 9 |
|
|
2022
Q1 | $24.5M | Buy |
565,951
+26,984
| +5% | +$1.17M | 8.44% | 7 |
|
|
2021
Q4 | $27M | Sell |
538,967
-6,616
| -1% | -$332K | 9.37% | 7 |
|
|
2021
Q3 | $34.7M | Buy |
545,583
+1,878
| +0.3% | +$119K | 10.89% | 5 |
|
|
2021
Q2 | $39.1M | Sell |
543,705
-3,934
| -0.7% | -$283K | 13.28% | 5 |
|
|
2021
Q1 | $40.4M | Sell |
547,639
-6,007
| -1% | -$443K | 13.98% | 3 |
|
|
2020
Q4 | $40.6M | Buy |
553,646
+16,268
| +3% | +$1.19M | 11.87% | 3 |
|
|
2020
Q3 | $29.5M | Buy |
537,378
+15,871
| +3% | +$871K | 9.38% | 6 |
|
|
2020
Q2 | $34.7M | Buy |
521,507
+34,232
| +7% | +$2.28M | 9.43% | 6 |
|
|
2020
Q1 | $29.8M | Buy |
487,275
+147,456
| +43% | +$9.02M | 9.59% | 6 |
|
|
2019
Q4 | $29.9M | Buy |
+339,819
| New | +$29.9M | 10.2% | 7 |
|